Pfizer Inc. (ETR:PFE)
Market Cap | 131.40B |
Revenue (ttm) | 61.46B |
Net Income (ttm) | 7.76B |
Shares Out | n/a |
EPS (ttm) | 1.36 |
PE Ratio | 16.94 |
Forward PE | n/a |
Dividend | 1.58 (6.78%) |
Ex-Dividend Date | Jan 24, 2025 |
Volume | 50,081 |
Average Volume | 68,908 |
Open | 23.24 |
Previous Close | 23.30 |
Day's Range | 22.97 - 23.27 |
52-Week Range | 22.97 - 29.50 |
Beta | 0.54 |
RSI | 34.48 |
Earnings Date | Apr 29, 2025 |
About Pfizer
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]
Financial Performance
In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.
Financial numbers in USD Financial StatementsNews

6 Ultra SWANs Potentially Set To Soar In 2025
The Dividend Kings Fortress Portfolio, composed exclusively of Ultra SWAN stocks (highest-quality blue chips), has delivered strong returns over the last six years. Just 20% of the holdings produced 7...

Pfizer: Value Play or Past Its Prime?
Pfizer ran what could be the largest tax dodging scheme among Big Pharma: Senator

Did Pfizer Delay Covid Vaccine Announcement Until After 2020 Election? Here's What We Know.
Federal investigators are investigating claims suggesting Pfizer delayed announcing test results of its Covid vaccine until after the 2020 presidential election, the Wall Street Journal reported, bols...

Biotech stocks have been hit hard. Why they're a great value now.
Biotech is one of the U.S. stock market's most unloved sectors. But several indicators suggest that a bottom in sentiment could be near, and that's normally a good time to buy.

Why Pfizer Is My Largest Healthcare Position

Feds probe tip that Pfizer delayed announcing COVID vaccine's success until after 2020 election: report
The report said GSK's former head of vaccine development, Philip Dormitzer, who joined the company after working at rival Pfizer, had told his GSK colleagues about the delay.
Market Today: Pfizer Faces Investigation, Microsoft Scales Back Data Centers
Market Today: Pfizer Faces Investigation, Microsoft Scales Back Data Centers

Pfizer Shares Are Down Today: What's Going On?
Pfizer Inc. (NYSE: PFE) shares are trading lower on Wednesday after a Wall Street Journal report revealed U.S. prosecutors are investigating a claim about the timing of Pfizer's COVID-19 vaccine anno...

US prosecutors probe tip about timing of Pfizer's COVID vaccine, WSJ reports
Federal prosecutors in Manhattan are probing a claim brought by GSK that Pfizer delayed announcing the success of its COVID-19 vaccine in 2020 until after that year's election, the Wall Street Journal...
Pfizer Stock Slips After Report on Vaccine Timing Probe
Pfizer drops after report on U.S. probe related to its COVID vaccine success

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine
Claim came to the U.S. attorney's office in Manhattan via Pfizer rival GSK.
Pfizer Is Trading As If It's 2009 Again

ForexLive Asia-Pacific FX news wrap: White House says scaling back April 2 tariff plan
Bank of England Governor Bailey speaks Monday, March 24, 2025: "Growth in the UK Economy" Barclays says further PBOC easing is becoming increasingly unavoidable The chair of UK investment bank Cavendi...

China Courts Apple, Pfizer, Eli Lilly Amid US Pressure, Vice Premier Says Beijing 'Will Continue To Improve The Business Environment'
On Sunday, Chinese Vice Premier He Lifeng met with top executives from Apple Inc. (NASDAQ: AAPL), Pfizer Inc. (NYSE: PFE), Mastercard Inc. (NYSE: MA), Eli Lilly and Co. (NYSE: LLY), Cargill , and ...

China vice premier He Lifeng met heads of Apple, Pfizer, MasterCard, Eli Lilly, Cargill
China vice premier he Lifeng met with heads of Apple, Pfizer, MasterCard, Eli Lilly, Cargill and others at business forum on Sunday – commerce ministry. This article was written by Eamonn Sheridan at ...
Notable healthcare headlines for the week: Pfizer, Sanofi, Sarepta Therapeutics and Medtronic in focus

Pfizer: Bulls Need To Check Out Its Graham P/E
Pfizer's attractive dividend yield and low P/E ratio make it appealing. Learn why PFE stock's valuation risks may be higher due to bleak growth and debt levels.
Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio
Alnylam stock jumped Friday after the drugmaker won a second Food and Drug Administration approval for its drug, Amvuttra.

Buy 4 Ideal 'Safer' February Dividends, Out Of 40 Choices From Readers
Since May 2017, reader-selected dividend-paying stocks have been featured, with valuable reader feedback improving accuracy and direction. My Dogs of The Week portfolios are available for Dividend Dog...

3 Reasons Pfizer Stock Could Be a Steal of a Deal in 2025

More Dividends, Less Drama: 3 Of My Favorite Dividend Stocks (5-7% Yield)
Uncertainty dominates the market, with consumer sentiment and business confidence at multi-year lows. Inflation fears persist, and policy support seems unlikely. Amid rising risks, I favor high-yield ...

Vaccine success 'most profound moment of my life'
Pfizer scientist Dr Nicholas Kitchin shares the moment he heard the the Covid jab was a success.

Sensodyne toothpaste maker Haleon now an independent company after Pfizer sells stake
Shares in the consumer health group - originally a joint venture between Pfizer and GSK - are up nearly a fifth since it joined the stock market in 2022.